India has become the first country to offer a DNA vaccine to 30 other nations [1], Dr. Jitendra Singh said.
This shift in medical exports and domestic policy signals India's intent to move from being a provider of basic generics to a leader in high-tech preventive medicine. By expanding its role in global health initiatives, the country aims to reshape how the international community perceives its healthcare infrastructure.
Dr. Singh, who serves as the Union Minister of State for the Ministry of Science and Technology and the Ministry of Earth Sciences, said the world’s view of India’s health sector has changed. He said this evolution is due to a combination of technological advancement and a strategic focus on accessibility.
According to the minister, India is now manufacturing high-quality healthcare products that are both accessible and affordable [2]. This domestic manufacturing push is designed to lower costs while maintaining a standard of quality that allows for competitive international exports.
Beyond manufacturing, Dr. Singh said there is a change in behavior among the domestic population. He said more Indians are opting for preventive healthcare, and regular check-ups [3]. This transition toward prevention is intended to reduce the long-term burden on the hospital system by addressing health issues before they become critical.
The offer of the DNA vaccine to 30 countries [1] serves as a primary example of this new strategy. By leveraging its capacity for mass production and scientific research, India is positioning itself as a critical partner in global pandemic preparedness and disease prevention.
“India is now manufacturing high‑quality healthcare products that are both accessible and affordable.”
India is attempting to pivot its global health identity from the 'pharmacy of the world'—known primarily for low-cost generic drugs—to a hub of biotech innovation. The deployment of DNA vaccines and the internal shift toward preventive care suggest a strategy to increase the value of its medical exports and improve public health outcomes through early intervention rather than reactive treatment.
